Human parvovirus B19 IgM antibodies among blood donor in Basra

  • Wijdan Nazar Ibraheim Department of Microbiology, College of Medicine, University of Basrah
Keywords: blood, donor, B19 virus, IgM

Abstract

  One of the main methods for B 19 Parvovirus transmission is by blood and its products. Screening test for this virus is not yet applicable; in spite of its association with some sever complication. So that the aim of this study was to estimate the level of HPVB19 IgM antibodies among blood donor in centre of Basra. A total of 189 blood samples were drawn from healthy blood donor attending the blood bank in Basrah governorate   from the period of January –May 2016. Detection of parvovirus B19 IgM antibodies was done using a solid phase enzyme-linked immunosorbent assay. In this study the researcher found that highest seropositivity were found among age group   30-39 years (62.6%) and the lowest level among those above 40 years (0%), with overall prevalence of IgM 51.1% this high percentage may related to the time of sampling which coincide with the maximum period of infectivity which was more common in late winter, spring, and early summer. Regarding the association between ABO blood groups and susceptibility to infection: the rate of infection more among those with blood group O+ and B+ (54.9%) and (27.5%) respectively this is depend on the availability of blood antigen P which act as receptors for this virus, and highest level of HPV IgM was found among the taxi drivers  so in conclusion: Screening for B19 virus antibodies is recommended together with other viruses which transmitted by blood transfusion to avoid transmission of this important virus to vulnerable risky group.

References

Bärbel Kaufmann, Alan A. Simpson, and Michael G. Rossmann. The structure of human parvovirus B19. Proc Natl Acad Sci U S A. 2004 Aug 10; 101(32): 11628–11633.

Blaeser F., Kelly M., Siegrist K. Critical function of the CD40 pathway in parvovirus B19 infection revealed by a hypomorphic CD40 ligand mutation. ClinImmunol. 2005; 117:231–237. [PubMed]

Cassinotti P., Siegl G. Quantitative evidence for persistence of human parvovirus B19 DNA in an immunocompetent individual. Eur J ClinMicrobiol Infect Dis. 2000; 19:886–887. [PubMed]

Chisaka H , Morita E, Yaegashi N, Sugamura K. Parvovirus B19 and the pathogenesis of anaemia. Rev Med Virol. 2003 Nov-Dec; 13(6):347-59

H. L. Zaaijer, Koppelman and C. P. Farrington. Parvovirus B19 Viraemia in Dutch Blood Donors. Epidemiology and Infection. Vol. 132, No. 6 (Dec., 2004), pp. 1161-1166.

Jensen IP, Thorsen P, Jeune B, Møller BR, Vestergaard BF. An epidemic of parvovirus B19 in a population of 3,596 pregnant women: a study of sociodemographic and medical risk factors. BJOG. 2000 May; 107(5):637-43

Johargy AK.seroprevalence of erythrovirus B19 IgG among Saudi blood donors in Makkah,Saudi Arabia . J Family Community Med. 2009 Sep; 16(3):111-4.

Ke L , He M, Li C, Liu Y, Gao L, Yao F, Li J, Bi X, Lv Y, Wang J, Hirsch ML, Li W. The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers. Transfusion. 2011 Sep;51(9):1909-18. doi: 10.1111/j.1537-2995.2011.03067. x. Epub 2011 Mar 7.

Manaresi E, Gallinella G. Seroprevalence of parvovirus BI9 among Italians blood donors. Epidemi. of infect. 2004; 132 (5):857-862.

Musa, Sunday A. U Prof. B anwat, E dmund B Zhakom Ponfa; Rumji, E lisha M Yakubu, Rebecca; Yakubu, R ebecca K. and Rufai, O lalekan A. Risk of Transfusion-Transmitted Human Parvovirus B19 Infection in Anyigba and Lokoja, Kogi State. Iosr Journal of Pharmacy Volume 3, Issue 3 (April 2013), Pp 66-70.

Satish Kumar , R.M. Gupta, Sourav Sen, R.S. Sarkar, J. Philip, Atul Kotwal,and S.H. Sumath. Seroprevalence of human parvovirus B19 in healthy blood donors. Med J Armed Forces India. 2013 Jul; 69(3): 268–272.

Smith-Whitley K, Zhao H, Hodinka RL, Kwiatkowski J, Cecil R, Cecil T, Cnaan A, Ohene-Frempong K. Epidemiology of human parvovirus B19 in children with sickle cell disease. Blood. 2004 Jan 15;103(2):422-7. Epub 2003 Oct 2.

Wei O, Li Y. prevalence of anti human parvovirus anti-body among blood donors in Jilin province China. 2006 Jun; 20(2): 60-2.

Yoto, Y., Kudoh, T., Haseyama, K., Suzuki, N., Oda, T., Katoh, T. and Chiba, S. Incidence of Human Parvovirus B19 DNA Detection in Blood Donors. British Journal of Haematology (2008). 91 (4): 1017 - 1018. Available at www3.interscience.wiley.com/journa

Young NS, Brown KE."Parvovirus B19". N Engl J Med. (February 2004). 350 (6):586–597.Doi :10.1056/NEJMra030840. PMID 14762186

Published
2020-10-08
Section
Articles